Drug & medication recalls

AndroGel 1 recalled over temperature-control failures

Recall date
September 8, 2017
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
AbbVie Inc. recalls AndroGel (testosterone gel) 1.62%, 88 gm metered-dose pump, 20.25 mg of testosterone per pump actuation, 60 metered pum…
Recall number
D-0033-2018
FDA classification
Class III
Brand / firm
AbbVie Inc.
Sold / distributed
AZ

Why it was recalled

Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.

Class III means the product violates regulations but is not likely to cause harm.

What was recalled

AndroGel (testosterone gel) 1.62%, 88 gm metered-dose pump, 20.25 mg of testosterone per pump actuation, 60 metered pump actuations, Rx Only, Marketed by: AbbVie Inc., North Chicago, IL 60064 USA. NDC: 0051-8462-33

Get recall alerts

Free email alert whenever AbbVie Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: AbbVie Inc.